APNIMED, INC.
Profile
Company Names
APNIMED, INC.
Addresses
39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA 02138
20 HOLYOKE STREET, CAMBRIDGE, MA 02138
19 WARE ST. APT. 3, CAMBRIDGE, MA 02138
Phone Numbers
617-500-8880
617-394-8172
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, OTHER HEALTH CARE
Year Incorporated:
2017
State Incorporated:
DELAWARE
Total Amount Raised:
$284,325,535.00
Number of Funding Rounds:
9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2026-03-11
$24,999,994.00
$24,999,994.00
$0.00
Equity
8
2025-09-17
$35,000,000.00
$35,000,000.00
$0.00
Debt
7
2025-04-23
$16,499,982.00
$16,499,982.00
$0.00
Equity
6
2023-11-01
$0.00
$37,499,980.00
$37,499,980.00
Equity
5
2022-12-22
$79,749,950.00
$79,749,950.00
$0.00
Equity
4
2022-04-28
$62,499,913.00
$62,499,913.00
$0.00
Equity
3
2021-03-12
$24,999,982.00
$24,999,982.00
$0.00
Equity
2
2020-03-31
$15,000,000.00
$15,000,000.00
$0.00
Equity
1
2018-06-25
$25,575,714.00
$25,575,714.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
GERALD
CHAN
DIRECTOR
CRITICAL BIOLOGICS CORP
| MORNINGSIDE CHINA TMT FUND II, L.P.
| SYNCHRONEURON INC.
| NATURAL POLYMER INTERNATIONAL CORP
| APELLIS PHARMACEUTICALS, INC.
| MORNINGSIDE CHINA TMT FUND III CO-INVESTMENT, L.P.
| MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND, L.P.
| MORNINGSIDE CHINA TMT FUND III, L.P.
| MORNINGSIDE CHINA TMT TOP UP FUND LP
| MORNINGSIDE CHINA TMT FUND IV CO-INVESTMENT, L.P.
| MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND II, L.P.
| MORNINGSIDE CHINA TMT FUND IV, L.P.
| ATEA PHARMACEUTICALS, INC.
| GOOD FOODIE CO
| KEZAR LIFE SCIENCES, INC.
| APNIMED, INC.
| STAVROS TECHNOLOGIES, INC.
| STEALTH BIOTHERAPEUTICS CORP
| LUMIRADX LTD
| LINUS HEALTH, INC.
| ANACONDA, INC.
| NEUTROLIS INC.
| COGNITO THERAPEUTICS LTD.
| COGNITO THERAPEUTICS GROUP, INC.
ISAAC
CHENG
DIRECTOR
LIQUIDIA TECHNOLOGIES INC
| BIOSCALE INC
| EDISON PHARMACEUTICALS INC
| ATREAON, INC.
| SYNCHRONEURON INC.
| AMYLYX PHARMACEUTICALS, INC.
| TORPEDO DIAGNOSTICS, INC.
| DNATRIX INC
| ADJUVANCE TECHNOLOGIES INC.
| INCARDA THERAPEUTICS, INC.
| MEISSA VACCINES INC
| TALLAC THERAPEUTICS, INC.
| APNIMED, INC.
| MEDRHYTHMS, INC.
CHRIS
DIMITROPOULOS
DIRECTOR
PAUL
FONTEYNE
DIRECTOR
STEFAN
LARSON
DIRECTOR
LAWRENCE
MILLER
EXECUTIVE OFFICER, DIRECTOR
LAWRENCE
G.
MILLER
EXECUTIVE OFFICER, DIRECTOR
DENNIS
MOLNAR
DIRECTOR, EXECUTIVE OFFICER
MICHAEL
ROGERS
EXECUTIVE OFFICER
GARY
SENDER
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-03-11
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2025-09-17
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2025-09-17
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2025-09-17
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-04-23
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

